Karden A, Fragner T, Feichtinger C, Strizek J, McDermott D, Grabovac I
Harm Reduct J. 2025; 22(1):17.
PMID: 39955527
PMC: 11829356.
DOI: 10.1186/s12954-025-01168-1.
Corkery J, Copeland C, Ream S, Streete P, Schifano F
J Clin Med. 2025; 14(2).
PMID: 39860433
PMC: 11765549.
DOI: 10.3390/jcm14020427.
Murithi C, Kabaru J, Patel N
IBRO Neurosci Rep. 2025; 18:1-5.
PMID: 39764355
PMC: 11700289.
DOI: 10.1016/j.ibneur.2024.11.015.
Sorbello J, Devilly G
Harm Reduct J. 2024; 21(1):226.
PMID: 39709443
PMC: 11662552.
DOI: 10.1186/s12954-024-01122-7.
Zhang S, Qi X, Wang Y, Fang K
Front Public Health. 2024; 12:1470809.
PMID: 39534741
PMC: 11554507.
DOI: 10.3389/fpubh.2024.1470809.
The Mental Suffering of Cocaine-Addicted Patients: A Retrospective Analysis of Personality Disorders' Prevalence and Their Association with Psychopathological Symptoms.
Giordano F, Guidotti S, Scategni F, Cuzzola D, Pruneti C
Eur J Investig Health Psychol Educ. 2024; 14(10):2787-2799.
PMID: 39452178
PMC: 11507854.
DOI: 10.3390/ejihpe14100183.
Facilitators of and obstacles to practitioners' adoption of harm reduction in cannabis use: a scoping review.
Haddad R, Dagenais C, Fallu J, Hunh C, DArcy L, Hot A
Harm Reduct J. 2024; 21(1):178.
PMID: 39354543
PMC: 11445962.
DOI: 10.1186/s12954-024-01093-9.
[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].
Jungwirth J, Bavato F, Quednow B
Nervenarzt. 2024; 95(9):803-810.
PMID: 39196383
PMC: 11374839.
DOI: 10.1007/s00115-024-01727-0.
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.
Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F
CNS Drugs. 2024; 38(10):771-789.
PMID: 39033264
DOI: 10.1007/s40263-024-01101-3.
A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.
Heal D, Gosden J, Smith S
Front Psychiatry. 2024; 15:1322434.
PMID: 38915848
PMC: 11194422.
DOI: 10.3389/fpsyt.2024.1322434.
Activation of STING signaling aggravates chronic alcohol exposure-induced cognitive impairment by increasing neuroinflammation and mitochondrial apoptosis.
Lin X, Li X, Li C, Wang H, Zou L, Pan J
CNS Neurosci Ther. 2024; 30(3):e14689.
PMID: 38516831
PMC: 10958405.
DOI: 10.1111/cns.14689.
Symptom reduction in mal de débarquement syndrome with attenuation of the velocity storage contribution in the central vestibular pathways.
Maruta J, Cho C, Raphan T, Yakushin S
Front Rehabil Sci. 2024; 5:1331135.
PMID: 38486679
PMC: 10937418.
DOI: 10.3389/fresc.2024.1331135.
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada.
Chrenek C, Duong B, Khullar A, McRee C, Thomas R, Swainson J
Front Psychiatry. 2024; 14:1283733.
PMID: 38260793
PMC: 10801061.
DOI: 10.3389/fpsyt.2023.1283733.
Molecular and Medical Aspects of Psychedelics.
Wojtas A, Golembiowska K
Int J Mol Sci. 2024; 25(1).
PMID: 38203411
PMC: 10778977.
DOI: 10.3390/ijms25010241.
Twitter activity surrounding the Finnish green party's cannabis legalisation proposal: A mixed-methods analysis.
Unlu A, Hupli A
Nordisk Alkohol Nark. 2023; 40(6):625-645.
PMID: 38045011
PMC: 10688398.
DOI: 10.1177/14550725231171022.
An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study.
Carton L, Bastien A, Cherot N, Caron C, Deheul S, Cottencin O
Dialogues Clin Neurosci. 2023; 25(1):101-111.
PMID: 37837439
PMC: 10578082.
DOI: 10.1080/19585969.2023.2268063.
Sex-specific and ethnicity-specific differences in MINOCA.
La S, Beltrame J, Tavella R
Nat Rev Cardiol. 2023; 21(3):192-202.
PMID: 37775559
DOI: 10.1038/s41569-023-00927-6.
Effects of smoking on sleep architecture and ventilatory parameters including apneas: Results of the Tab-OSA study.
Mauries S, Bertrand L, Frija-Masson J, Benzaquen H, Kalamarides S, Sauvage K
Sleep Med X. 2023; 6:100085.
PMID: 37736106
PMC: 10509708.
DOI: 10.1016/j.sleepx.2023.100085.
Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City.
Palamar J, Rutherford C, Le A, Keyes K
J Psychoactive Drugs. 2023; 56(4):467-474.
PMID: 37605471
PMC: 10879452.
DOI: 10.1080/02791072.2023.2240322.
Methylphenidate as a treatment option for substance use disorder: a transdiagnostic perspective.
van Ruitenbeek P, Franzen L, Mason N, Stiers P, Ramaekers J
Front Psychiatry. 2023; 14:1208120.
PMID: 37599874
PMC: 10435872.
DOI: 10.3389/fpsyt.2023.1208120.